IRIS
RAIMONDO, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 13.038
NA - Nord America 12.247
AS - Asia 6.387
SA - Sud America 2.172
Continente sconosciuto - Info sul continente non disponibili 460
AF - Africa 207
OC - Oceania 18
Totale 34.529
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.973
RU - Federazione Russa 6.595
SG - Singapore 2.509
CN - Cina 2.003
BR - Brasile 1.867
IE - Irlanda 1.600
SE - Svezia 1.418
IT - Italia 889
HK - Hong Kong 687
DE - Germania 582
UA - Ucraina 408
FR - Francia 373
VN - Vietnam 363
FI - Finlandia 302
PL - Polonia 268
GB - Regno Unito 251
IN - India 182
CA - Canada 127
BD - Bangladesh 102
AR - Argentina 96
BE - Belgio 76
MX - Messico 68
TR - Turchia 68
AT - Austria 59
ID - Indonesia 59
ZA - Sudafrica 59
IQ - Iraq 56
EC - Ecuador 52
NL - Olanda 47
CO - Colombia 45
JP - Giappone 44
ES - Italia 42
PK - Pakistan 41
MA - Marocco 38
UZ - Uzbekistan 37
CZ - Repubblica Ceca 31
VE - Venezuela 28
CI - Costa d'Avorio 25
AE - Emirati Arabi Uniti 23
PY - Paraguay 23
CL - Cile 19
JM - Giamaica 18
KE - Kenya 18
SA - Arabia Saudita 18
AZ - Azerbaigian 17
JO - Giordania 17
LT - Lituania 17
PH - Filippine 17
BO - Bolivia 15
NP - Nepal 15
TN - Tunisia 15
DZ - Algeria 14
IL - Israele 14
LB - Libano 14
PE - Perù 14
IR - Iran 13
KZ - Kazakistan 13
KG - Kirghizistan 12
MY - Malesia 12
UY - Uruguay 12
CR - Costa Rica 11
GR - Grecia 11
NZ - Nuova Zelanda 11
OM - Oman 9
EG - Egitto 8
GT - Guatemala 8
HN - Honduras 8
PT - Portogallo 8
AU - Australia 7
BG - Bulgaria 7
DO - Repubblica Dominicana 7
EE - Estonia 7
BZ - Belize 6
ET - Etiopia 6
LV - Lettonia 6
SV - El Salvador 6
AL - Albania 5
BY - Bielorussia 5
KW - Kuwait 5
NO - Norvegia 5
PS - Palestinian Territory 5
SN - Senegal 5
AM - Armenia 4
AO - Angola 4
KR - Corea 4
PA - Panama 4
RO - Romania 4
RS - Serbia 4
SY - Repubblica araba siriana 4
TH - Thailandia 4
BN - Brunei Darussalam 3
CH - Svizzera 3
DK - Danimarca 3
EU - Europa 3
LY - Libia 3
MD - Moldavia 3
NI - Nicaragua 3
PR - Porto Rico 3
QA - Qatar 3
BA - Bosnia-Erzegovina 2
Totale 34.037
Salva come PNG Salva come JPEG
Città #
Ashburn 2.300
Moscow 2.022
Dublin 1.599
Singapore 1.457
Dallas 1.343
Chandler 1.074
Jacksonville 838
Nyköping 837
Beijing 686
Hong Kong 684
San Jose 614
Messina 414
Council Bluffs 385
The Dalles 338
Los Angeles 270
Ann Arbor 253
Warsaw 250
Princeton 247
Medford 223
Lauterbourg 216
Cambridge 188
Des Moines 180
Munich 167
São Paulo 159
Dearborn 145
New York 136
Ho Chi Minh City 130
Boardman 118
Buffalo 92
Woodbridge 85
Houston 82
Santa Clara 82
Wilmington 81
Jinan 74
Tianjin 74
Brussels 72
Frankfurt am Main 69
Hanoi 69
Redondo Beach 66
Orem 64
Helsinki 62
Guangzhou 59
San Mateo 58
Rio de Janeiro 57
Nanjing 54
Shenyang 54
Belo Horizonte 53
Brasília 53
Turku 50
Rome 47
Seattle 44
Chennai 43
Tokyo 42
Nuremberg 40
Brooklyn 39
Phoenix 39
Hebei 38
Columbus 37
Falls Church 37
Vienna 37
Pune 36
Shanghai 36
Chicago 35
Haikou 35
Montreal 32
Shenzhen 32
Zhengzhou 32
Tashkent 31
Atlanta 30
Jakarta 30
Stockholm 30
Catania 29
Hyderabad 28
Porto Alegre 28
San Francisco 27
Baghdad 26
Curitiba 26
Abidjan 25
Amsterdam 25
Bremen 25
Boston 24
Johannesburg 24
Lancaster 24
Brno 22
Denver 22
Dong Ket 22
London 22
Ottawa 22
Guarulhos 21
Mexico City 21
Campinas 20
Hangzhou 20
Nanchang 20
Ningbo 20
Manchester 19
Milan 19
Mumbai 19
Poplar 19
Quito 19
Dhaka 18
Totale 20.141
Salva come PNG Salva come JPEG
Nome #
Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels. 386
Analysis of haemochromatosis gene mutations in a population from the Mediterranean Basin. 282
Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography 276
Antibody to hepatitis B virus core antigen positivity is a predictor of non-alcoholic fatty liver disease severity 272
PIVKA-II is a useful tool for diagnostic characterization of ultrasound-detected liver nodules in cirrhotic patients 266
Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma. 264
Atrial fibrillation in patients with cirrhosis 256
Evaluation of CTNNB1 and TP53 variability in patients with hepatocellular carcinoma and occult hepatitis B virus infection 244
Hepatitis B virus (HBV) markers and HBV-DNA in serum and liver tissue of patients with acute exacerbation of chronic type B hepatitis 232
Lack of the NS5B S282T mutation in HCV isolates from liver tissue of naive patients with HCV genotype-1b infection. 230
Free episomal and integrated HBV DNA In HBsAg-negative patients with intrahepatic cholangiocarcinoma 226
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV 220
Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus 218
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients 218
Risk Factors Associated with NASH in Obese Patients Undergoing Bariatric Surgery NASH and bariatric surgery 218
A combination of different diagnostic tools allows identification of inactive hepatitis B virus carriers at a single time point evaluation 217
HBE ANTIBODY UNRELATED TO E-MINUS HEPATITIS-B VIRUS VARIANT INFECTION IN PATIENTS WITH CHRONIC TYPE-D HEPATITIS 216
Frequency of somatic mutations in TERT promoter, TP53 and CTNNB1 genes in patients with hepatocellular carcinoma from Southern Italy 215
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study 213
Case Report: Atrial Fibrillation After Intravenous Administration of Iodinated Contrast Medium in a Patient With Hepatocellular Carcinoma 212
Hepatitis B virus and hepatitis C virus co-infection: additive players in chronic liver disease? 211
Does the margin width influence recurrence rate in liver surgery for hepatocellular carcinoma smaller than 5 cm? 211
NS3 Variability in Hepatitis C Virus Genotype 1A Isolates from Liver Tissue and Serum Samples of Treatment-Naïve Patients with Chronic Hepatitis C 210
Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases 205
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B ‘e’ antigen-negative chronic hepatitis B genotype D 205
Erectile dysfunction in compensated liver cirrhosis 203
Hepatitis B-DNA replication and histological patterns in liver biopsy specimens of chronic HBsAg positive patients with and without hepatitis delta virus superinfection. 202
A GENETIC-POLYMORPHISM OF THE APOLIPOPROTEIN AI-CIII GENE- CLUSTER IS ASSOCIATED WITH CORONARY HEART-DISEASE IN NON- INSULIN-DEPENDENT DIABETES-MELLITUS 202
An evaluation of transient elastography in the discrimination of HBeAg-negative disease from inactive hepatitis B carriers 201
Analysis of occult hepatitis B virus infection in liver tissue of HIV patients with chronic hepatitis C. 200
Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate 198
Occult hepatitis B virus infection predicts non-alcoholic steatohepatitis in severely obese individuals from Italy 197
Control of cccDNA function in hepatitis B virus infection. 196
Delta agent infection in acute hepatitis and chronic HBsAg carriers with and without liver disease. 196
Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection 195
Elective endoscopic variceal ligation is not a risk factor for bacterial infection in patients with liver cirrhosis 195
Behaviour of occult HBV infection in HCV-infected patients under treatment with direct-acting antivirals 193
Outcome of cutaneous psoriasis in hepatitis C virus-infected patients treated with Direct-Acting Antiviral therapy 190
HEPATITIS-B VIRUS VARIANT, WITH A DELETION IN THE PRES2 AND 2 TRANSLATIONAL STOP CODONS IN THE PRECORE REGIONS, IN A PATIENT WITH HEPATOCELLULAR-CARCINOMA 189
Exacerbation of chronic liver disease due to hepatitis B surface antigen after delta infection. 189
Fibroscan: a new non-invasive method for evaluation of liver dysfunction in Turner syndrome 188
ALFA-INTERFERON TREATMENT INDUCES INSULIN AUTOANTIBODIES IN PATIENTS WITH CHRONIC VIRAL-HEPATITIS 186
Cirrhosis related to wild-type HBV infection in siblings with A3 - B35 - Cw4 HLA class I phenotype. 185
[A glance into the past ... Southern and northern blot: really superseded?] 182
Mitochondrial DNA is a target of HBV integration 182
Analysis of HBV integration in mitochondrial DNA of HepAD38 cells by the high-throughput HBV integration sequencing and RNASeq approaches 180
Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients. 179
Is there a downgrading in the alert about the hepatitis B virus infection in Italy? 177
A 2010 update on occult hepatitis B infection. 177
Human hepatitis B virus negatively impacts the protective immune cross-talk between natural killer and dendritic cells 177
Rate of hepatocellular carcinoma diagnosis in cirrhotic patients with ultrasound‑detected liver nodules 177
Prevalence of hepatitis B and C viral infections in hospitalized patients with increased liver enzyme levels and with no known history of hepatic disease 176
Evaluation of liver enzyme levels and identification of asymptomatic liver disease patients in primary care 173
Celiac disease and non-organ-specific autoantibodies in patients with chronic hepatitis C virus infection 173
Clinical virology of hepatitis B virus infection 172
Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis 170
Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy 169
A NEW HEPATITIS-B VIRUS VARIANT IN A CHRONIC CARRIER WITH MULTIPLE EPISODES OF VIRAL REACTIVATION AND ACUTE HEPATITIS 168
Hepatitis B Virus Replication Is Regulated by the Acetylation Status of Hepatitis B Virus cccDNA-Bound H3 and H4 Histones 168
Hepatitis B virus (HBV) induces the expression of interleukin-8 that in turn reduces HBV sensitivity to interferon-alpha. 168
Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance 167
Is investigation of hepatitis C virus NS5A gene heterogeneity a tool for predicting long-lasting response to interferon therapy in patients with HCV-1b chronic hepatitis? 166
Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis. 165
Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia 164
Antibodies to hepatitis A virus in Italian patients with chronic liver disease 163
Low prevalence of hepatitis B and hepatitis C virus serum markers in a cohort of pregnant women from Southern Italy 162
Flavocoxid exerts a potent antiviral effect against hepatitis B virus. 162
Hepatitis B e antigen detection in formalin-fixed liver biopsy specimens. A tool to investigate wild-type and E-minus variant HBV infection. 161
Multicentre study of prevalence of HBV-associated delta infection and liver disease in drug-addicts. 160
Correlates of total homocysteine plasma concentration in type 2 diabetes 160
INTRAHEPATIC HDV RNA, HBV DNA, AND HBV RNAS QUANTIFICATIONS REVEAL SUPPRESSION OF HBV PREGENOME RNA PRODUCTION WITH MAINTENANCE OF PRES/S TRNSCRITION IN HDV/HBV CO-INFECTED PATIENTS 160
TT virus has a ubiquitous diffusion in human body tissues: analyses of paired serum and tissue samples. 159
Interrupted replication of hepatitis B virus in liver tissue of HBsAg carriers with hepatocellular carcinoma 158
The HCV Sicily Network: A web-based model for the management of HCV chronic liver diseases 158
Hepatitis B-DNA replication and histological patterns in liver biopsy specimens of chronic HBsAg positive patients with and without hepatitis delta superinfection. 157
Ipertransaminasemia persistente in una coorte di pazienti diabetici di tipo 2: prevalenza e correlazioni cliniche 157
Disease progression and liver cancer in the ferroportin disease. 157
Genomic heterogeneity of hepatitis B virus (HBV) and outcome of perinatal HBV infection. 156
Risk of occult hepatitis B virus infection reactivation in patients with solid tumours undergoing chemotherapy 156
Effectiveness of add-on Pegylated interferon alfa-2a therapy in a Lamivudine-treated patient with chronic hepatitis B 155
BILE DUCTOPENIA FOLLOWING THERAPY WITH SULPIRIDE 154
HEPATITIS B VIRUS INDUCES INTERLEUKIN-8 (IL8) PRODUCTION IN HEPATOCYTES AND IL-8 IN TURN INHIBITS INTERFERON ALFA ANTIVIRAL ACTIVITY 154
Hepatitis B Virus Causes Epigenetic Induction of Interleukin-8Production which in Turn Inhibits Interferon-alfa Antiviral Activity 154
Obesity and liver cancer 154
Monofocal hepatocellular carcinoma: How much does size matter? 152
High prevalence of non-organ-specific autoantibodies in hepatitis C virus-infected cirrhotic patients from southern Italy. 151
Effetto della menopausa sui livelli di omocisteina e sul polimorfismo C677T della metilenetetraidrofolato reduttasi nelle donne con diabete mellito di tipo 2 151
Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses. 151
HISTOLOGICAL BEHAVIOR OF CHRONIC HEPATITIS IN PATIENTS TREATED WITH ALPHA-INTERFERON 150
IPERTRANSAMINASEMIAQ PERSISTENTE IN UNA COORTE DI PAZIENTI DIABETICI DI TIPO 2: PREVALENZA E CORRELAZIONI CLINICHE. 150
ABNORMAL ALANINE AMINOTRANSFERASE ACTIVITY REFLECTS EXPOSURE TO HEPATITIS-C VIRUS IN HEMODIALYSIS-PATIENTS 149
Outcome of liver disease and response to interferon treatment are not influenced by hepatitis B virus core gene variability in children with chronic type B hepatitis. 149
Pattern of macrovascular invasion in hepatocellular carcinoma 148
The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection. 148
Infection with HBV preS/S Variants is Highly Prevalent and Influences Amount of Circulating HBsAg Independently of Serum HBV DNA Levels and Response to Interferon Therapy in Chronic Hepatitis B 148
Efficacy of high dose of recombinant alpha 2b interferon on long term response in chronic hepatitis C and cirrhosis: prospective randomized multicentre study 147
NS3 genetic variability in hepatitis C virus genotype-1b isolates from liver specimens and blood samples of treatment naïve patients with chronic hepatitis C 147
Seroprevalence of hepatitis B virus and hepatitis C virus infections in elderly residents in nursing homes in Southern Italy 146
The changing scenario of hepatocellular carcinoma in Italy: an update 146
Molecular analyses of TT virus in paired and tissue samples from 150 patients with either hepatic or non-hepatic disease 145
Totale 18.593
Salva come PNG Salva come JPEG
Categoria #
all - tutte 115.206
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 115.206
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.619 0 153 48 58 95 33 126 59 29 281 216 521
2022/20234.528 334 464 224 320 309 451 81 246 1.896 31 134 38
2023/20241.189 81 180 54 104 100 197 19 248 6 56 34 110
2024/20255.245 78 75 139 347 274 221 209 1.054 1.232 309 460 847
2025/202616.412 718 1.237 1.211 1.097 1.285 3.393 2.031 1.964 2.047 731 302 396
2026/2027943 480 463 0 0 0 0 0 0 0 0 0 0
Totale 34.529